Leukemia

ISSN	1476-5551
ISSN-L	0887-6924
IUID	5e77029e42224847a5f56e4de434a3c1
Modified	2020-11-27T13:12:54.430Z
Created	2018-12-05T08:35:06.693Z

Year 2025

PubMed DOI Crossref

Clinical and transcriptomic characterization of patients with chronic lymphocytic leukemia harboring t(14;19): an ERIC study.

Visentin A, Gaffo E, Fürstenau M, ..., Trentin L, Bortoluzzi S

Leukemia 39 (12) 2957-2967 [2025-12-00; online 2025-09-19]

PubMed DOI Crossref

OGG1 activation improves T cell resilience to oxidative stress after allo-SCT and T cell engager exposure.

Saul D, Lischer C, Bruns H, ..., Michel M, Mougiakakos D

Leukemia 39 (12) 3037-3041 [2025-12-00; online 2025-10-15]

PubMed DOI Crossref

SF3B1-mutant models of RNA mis-splicing uncover UBA1 as a therapeutic target in myelodysplastic neoplasms.

Thier J, Hofmann S, Kirchhof KM, ..., Moura PL, Lundin V

Leukemia 39 (11) 2801-2811 [2025-11-00; online 2025-08-26]

PubMed DOI Crossref

Genomic determinants of therapy response in ETV6::RUNX1 leukemia.

Oksa L, Moisio S, Maqbool K, ..., Lohi O, Heinäniemi M

Leukemia 39 (9) 2125-2139 [2025-09-00; online 2025-07-09]

PubMed DOI Crossref

Disease-specific U1 spliceosomal RNA mutations in mature B-cell neoplasms.

Nadeu F, Shuai S, Clot G, ..., Puente XS, Campo E

Leukemia 39 (9) 2076-2086 [2025-09-00; online 2025-06-30]

PubMed DOI Crossref

Nelarabine in T-cell acute lymphoblastic leukemia: intracellular metabolism and molecular mode-of-action.

Hormann FM, Rudd SG

Leukemia 39 (3) 531-542 [2025-03-00; online 2025-02-17]

Year 2024

PubMed DOI Crossref

The non-canonical BAF chromatin remodeling complex is a novel target of spliceosome dysregulation in SF3B1-mutated chronic lymphocytic leukemia.

Hägerstrand D, Oder B, Cortese D, ..., Sutton LA, Rosenquist R

Leukemia 38 (11) 2429-2442 [2024-11-00; online 2024-09-11]

PubMed DOI Crossref

The exon-junction complex helicase eIF4A3 holds therapeutic potential in acute myeloid leukemia.

Miliara S, Cozzi E, Zhong X, ..., Bartek J, Kanellis DC

Leukemia 38 (3) 663-666 [2024-03-00; online 2023-11-30]

Year 2023

PubMed DOI Crossref

Proteogenomic analysis of acute myeloid leukemia associates relapsed disease with reprogrammed energy metabolism both in adults and children.

Stratmann S, Vesterlund M, Umer HM, ..., Lehtiö J, Holmfeldt L

Leukemia 37 (3) 550-559 [2023-03-00; online 2022-12-26]

PubMed DOI Crossref

Preclinical efficacy of azacitidine and venetoclax for infant KMT2A-rearranged acute lymphoblastic leukemia reveals a new therapeutic strategy.

Cheung LC, Aya-Bonilla C, Cruickshank MN, ..., Malinge S, Kotecha RS

Leukemia 37 (1) 61-71 [2023-01-00; online 2022-11-15]

Year 2022

PubMed DOI Crossref

"Randomized phase II study of azacitidine ± lenalidomide in higher-risk myelodysplastic syndromes and acute myeloid leukemia with a karyotype including Del(5q)".

Rasmussen B, Göhring G, Bernard E, ..., Möllgård L, Hellström-Lindberg E

Leukemia 36 (5) 1436-1439 [2022-05-00; online 2022-03-11]

PubMed DOI Crossref

Loss of Y and clonal hematopoiesis in blood-two sides of the same coin?

Ljungström V, Mattisson J, Halvardson J, ..., Baliakas P, Forsberg LA

Leukemia 36 (3) 889-891 [2022-03-00; online 2021-11-01]

PubMed DOI Crossref

Covid-19 in patients with chronic lymphocytic leukemia: clinical outcome and B- and T-cell immunity during 13 months in consecutive patients.

Blixt L, Bogdanovic G, Buggert M, ..., Hansson L, Österborg A

Leukemia 36 (2) 476-481 [2022-02-00; online 2021-09-25]

Year 2021

PubMed DOI Crossref

COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study.

Chatzikonstantinou T, Kapetanakis A, Scarfò L, ..., Stamatopoulos K, Ghia P

Leukemia 35 (12) 3444-3454 [2021-12-00; online 2021-11-01]

Year 2020

PubMed DOI Crossref

S100A6 is a critical regulator of hematopoietic stem cells.

Grahn THM, Niroula A, Végvári Á, ..., Zubarev RA, Karlsson S

Leukemia 34 (12) 3323-3337 [2020-12-00; online 2020-06-19]

Abhishek Niroula DDLS Fellow

PubMed DOI Crossref

KIT pathway upregulation predicts dasatinib efficacy in acute myeloid leukemia.

Malani D, Yadav B, Kumar A, ..., Murumägi A, Kallioniemi O

Leukemia 34 (10) 2780-2784 [2020-10-00; online 2020-07-17]

Year 2019

PubMed DOI Crossref

Inhibition of SYK or BTK augments venetoclax sensitivity in SHP1-negative/BCL-2-positive diffuse large B-cell lymphoma.

Sasi BK, Martines C, Xerxa E, ..., Rosenquist R, Efremov DG

Leukemia 33 (10) 2416-2428 [2019-10-00; online 2019-03-14]

PubMed DOI Crossref

Different time-dependent changes of risk for evolution in chronic lymphocytic leukemia with mutated or unmutated antigen B cell receptors.

Moysiadis T, Baliakas P, Rossi D, ..., Ghia P, Stamatopoulos K

Leukemia 33 (7) 1801-1805 [2019-07-00; online 2019-01-24]

PubMed DOI Crossref

Immune cell constitution in bone marrow microenvironment predicts outcome in adult ALL.

Hohtari H, Brück O, Blom S, ..., Porkka K, Mustjoki S

Leukemia 33 (7) 1570-1582 [2019-07-00; online 2019-01-11]

PubMed DOI Crossref

PRR14L mutations are associated with chromosome 22 acquired uniparental disomy, age-related clonal hematopoiesis and myeloid neoplasia.

Chase A, Pellagatti A, Singh S, ..., Boultwood J, Cross NCP

Leukemia 33 (5) 1184-1194 [2019-05-00; online 2018-12-20]

Year 2018

PubMed DOI Crossref

Mutation, methylation, and gene expression profiles in dup(1q)-positive pediatric B-cell precursor acute lymphoblastic leukemia.

Gunnarsson R, Dilorenzo S, Lundin-Ström KB, ..., Isaksson A, Johansson B

Leukemia 32 (10) 2117-2125 [2018-10-00; online 2018-03-12]

PubMed DOI Crossref

Immune cell contexture in the bone marrow tumor microenvironment impacts therapy response in CML.

Brück O, Blom S, Dufva O, ..., Pellinen T, Mustjoki S

Leukemia 32 (7) 1643-1656 [2018-07-00; online 2018-06-20]

PubMed DOI Crossref

ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-update on methodological approaches and results interpretation.

Malcikova J, Tausch E, Rossi D, ..., Pospisilova S, European Research Initiative on Chronic Lymphocytic Leukemia (ERIC) — TP53 network

Leukemia 32 (5) 1070-1080 [2018-05-00; online 2018-02-02]

Year 2017

PubMed DOI Crossref

Validation of risk stratification models in acute myeloid leukemia using sequencing-based molecular profiling.

Wang M, Lindberg J, Klevebring D, ..., Lehmann S, Grönberg H

Leukemia 31 (10) 2029-2036 [2017-10-00; online 2017-02-07]

PubMed DOI Crossref

EGR2 mutations define a new clinically aggressive subgroup of chronic lymphocytic leukemia.

Young E, Noerenberg D, Mansouri L, ..., Rosenquist R, Damm F

Leukemia 31 (7) 1547-1554 [2017-07-00; online 2016-11-28]

PubMed DOI Crossref

Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: updated ERIC recommendations.

Rosenquist R, Ghia P, Hadzidimitriou A, ..., Davi F, Stamatopoulos K

Leukemia 31 (7) 1477-1481 [2017-07-00; online 2017-04-25]

PubMed DOI Crossref

Enhanced sensitivity to glucocorticoids in cytarabine-resistant AML.

Malani D, Murumägi A, Yadav B, ..., Aittokallio T, Kallioniemi O

Leukemia 31 (5) 1187-1195 [2017-05-00; online 2016-11-11]

PubMed DOI Crossref

Monitoring therapy responses at the leukemic subclone level by ultra-deep amplicon resequencing in acute myeloid leukemia.

Ojamies PN, Kontro M, Edgren H, ..., Wolf M, Kallioniemi O

Leukemia 31 (5) 1048-1058 [2017-05-00; online 2016-10-31]

PubMed DOI Crossref

Antigen receptor stereotypy in chronic lymphocytic leukemia.

Stamatopoulos K, Agathangelidis A, Rosenquist R, Ghia P

Leukemia 31 (2) 282-291 [2017-02-00; online 2016-11-04]

PubMed DOI Crossref

Induction of the 5S RNP-Mdm2-p53 ribosomal stress pathway delays the initiation but fails to eradicate established murine acute myeloid leukemia.

Jaako P, Ugale A, Wahlestedt M, ..., Lindström MS, Bryder D

Leukemia 31 (1) 213-221 [2017-01-00; online 2016-06-03]

Year 2016

PubMed DOI Crossref

Genomic disruption of the histone methyltransferase SETD2 in chronic lymphocytic leukaemia.

Parker H, Rose-Zerilli MJ, Larrayoz M, ..., Oscier DG, Strefford JC

Leukemia 30 (11) 2179-2186 [2016-11-00; online 2016-05-20]

Year 2015

PubMed DOI Crossref

Profound parental bias associated with chromosome 14 acquired uniparental disomy indicates targeting of an imprinted locus.

Chase A, Leung W, Tapper W, ..., Dumanski JP, Cross NC

Leukemia 29 (10) 2069-2074 [2015-10-00; online 2015-05-20]

PubMed DOI Crossref

Common variation at 12q24.13 (OAS3) influences chronic lymphocytic leukemia risk.

Sava GP, Speedy HE, Di Bernardo MC, ..., Allan JM, Houlston RS

Leukemia 29 (3) 748-751 [2015-03-00; online 2014-11-03]

PubMed DOI Crossref

Recurrent mutations refine prognosis in chronic lymphocytic leukemia.

Baliakas P, Hadzidimitriou A, Sutton LA, ..., Rosenquist R, European Research Initiative on CLL (ERIC)

Leukemia 29 (2) 329-336 [2015-02-00; online 2014-06-19]

Year 2014

PubMed DOI Crossref

Feasibility of targeted next-generation sequencing of the TP53 and ATM genes in chronic lymphocytic leukemia.

Mansouri L, Sutton LA, Ljungström V, ..., Nilsson M, Rosenquist R

Leukemia 28 (3) 694-696 [2014-03-00; online 2013-10-31]

PubMed DOI Crossref

On the way towards a 'CLL prognostic index': focus on TP53, BIRC3, SF3B1, NOTCH1 and MYD88 in a population-based cohort.

Cortese D, Sutton LA, Cahill N, ..., Mansouri L, Rosenquist R

Leukemia 28 (3) 710-713 [2014-03-00; online 2013-11-12]